Best Targeted Therapy Treatment Hospitals Worldwide

With advanced oncology infrastructure, Baby Memorial Hospital offers Targeted Therapy for patients with cancers that contain specific treatable molecular alterations. Established in 1987, the NABH accredited hospital is located in Calicut, India, and has 500 beds.

Targeted medicines may block signals that allow cancer cells to grow, divide, spread, or develop new blood vessels. The choice of therapy depends on the cancer type, stage, molecular profile, and previous treatments. Comprehensive diagnostic and biomarker testing is performed when appropriate to guide treatment selection.

Beijing GoBroad Boren Hospital aims at providing Targeted Therapy using advanced precision medicine technology and patient-centric oncology care techniques. The accredited hospital was established in 2014 in Beijing, China and has 200 beds to care for both domestic and international patients.

Targeted Therapy is a treatment option that targets specific human DNA and proteins that play a critical role in the growth and survival of cancerous cells. The therapy can be used as a standalone treatment or in combination with chemotherapy, radiotherapy, and other medications, depending on the patient's diagnostic results. Before proceeding with a treatment, medical experts conduct biopsy analyses and molecular tests to identify which treatment is most effective.

Shanghai GoBroad Cancer Hospital aims at providing Targeted Therapy using advanced precision medicine technology and patient-centric oncology care techniques. The accredited hospital was established in 2016 in Shanghai, China and has 700 beds to care for both domestic and international patients.

Targeted Therapy is a treatment option that targets specific human DNA and proteins that play a critical role in the growth and survival of cancerous cells. The therapy can be used as a standalone treatment or in combination with chemotherapy, radiotherapy, and other medications, depending on the patient's diagnostic results. Before proceeding with a treatment, medical experts conduct biopsy analyses and molecular tests to identify which treatment is most effective.

With advanced oncology infrastructure, GoBroad Shanghai Zhaxin Hospital and Shanghai Liquan Hospital offers Targeted Therapy for patients with cancers that contain specific treatable molecular alterations. Established in 2018, the accredited hospital is located in Shanghai, China, and has 300 beds.

Targeted medicines may block signals that allow cancer cells to grow, divide, spread, or develop new blood vessels. The choice of therapy depends on the cancer type, stage, molecular profile, and previous treatments. Comprehensive diagnostic and biomarker testing is performed when appropriate to guide treatment selection.

At GoBroad Healthcare (Hematology) Guangdong Research Center, patients can access Targeted Therapy supported by advanced molecular diagnostics and experienced oncology specialists. Established in 2018, the accredited hospital is located in Dongguan, China, and has 200 beds.

Targeted therapy is a form of precision medicine that focuses on specific features of cancer cells rather than affecting all rapidly dividing cells. Depending on the cancer type and biomarker, treatment may involve targeted medicines administered orally or intravenously. A detailed pathology and molecular assessment helps the oncology team select an appropriate treatment.

The state-of-the-art Targeted Therapy services offered by Marengo Asia Hospitals, Gurugram, using modern precision oncology techniques and internationally recognized treatment protocols, have been operational in Gurgaon, India. Founded in 2022, the NABH, NABL accredited hospital has 250 beds and provides cancer care facilities for all its local and overseas patients.

Targeted therapy is medicine developed to target specific molecular changes or proteins that affect the growth and survival of cancer cells. It is applicable only to certain cancers in which a relevant biomarker or genetic alteration is present. Prior to the start of the therapy, doctors may perform tumor profiling or molecular testing to check if the targeted medicine can help the patient.

The state-of-the-art Targeted Therapy services offered by Jaslok Hospital & Research Center, using modern precision oncology techniques and internationally recognized treatment protocols, have been operational in Mumbai, India. Founded in 1973, the NABH, JCI accredited hospital has 350 beds and provides cancer care facilities for all its local and overseas patients.

Targeted therapy is medicine developed to target specific molecular changes or proteins that affect the growth and survival of cancer cells. It is applicable only to certain cancers in which a relevant biomarker or genetic alteration is present. Prior to the start of the therapy, doctors may perform tumor profiling or molecular testing to check if the targeted medicine can help the patient.

At Shefaa Al Orman, patients can access Targeted Therapy supported by advanced molecular diagnostics and experienced oncology specialists. Established in 2016, the ISO accredited hospital is located in Luxor, Egypt, and has 350 beds.

Targeted therapy is a form of precision medicine that focuses on specific features of cancer cells rather than affecting all rapidly dividing cells. Depending on the cancer type and biomarker, treatment may involve targeted medicines administered orally or intravenously. A detailed pathology and molecular assessment helps the oncology team select an appropriate treatment.

SSO Cancer Hospital, Mumbai aims at providing Targeted Therapy using advanced precision medicine technology and patient-centric oncology care techniques. The NABH accredited hospital was established in 2022 in Mumbai, India and has 41 beds to care for both domestic and international patients.

Targeted Therapy is a treatment option that targets specific human DNA and proteins that play a critical role in the growth and survival of cancerous cells. The therapy can be used as a standalone treatment or in combination with chemotherapy, radiotherapy, and other medications, depending on the patient's diagnostic results. Before proceeding with a treatment, medical experts conduct biopsy analyses and molecular tests to identify which treatment is most effective.